Targeted blue nanoparticles as photoacoustic contrast agent for brain tumor delineation

AbstractDistinguishing a tumor from non-neoplastic tissue is a challenging task during cancer surgery. Several attempts have been made to use visible or fluorescent agents to aid in the visualization of a tumor during surgery. We describe a novel method to delineate brain tumors, using a highly sensitive photoacoustic imaging technique that is enhanced by tumor-targeting blue nanoparticles serving as a contrast agent. Experiments on phantoms and on rat brains, ex vivo, demonstrate the high sensitivity of photoacoustic imaging in delineating tumors containing contrast agent at a concentration much lower than needed for visualization by the naked eye. The limit of detection of the system for the nanoparticles is about 0.77 μg/mL in water (equivalent to 0.84 μmol/L Coomassie Blue dye). The present exploratory study suggests that photoacoustic imaging, when used with strongly optical absorbing contrast agents, could facilitate cancer surgery intraoperatively by revealing the distribution and extent of the tumor.

[1]  Olivier Jolliet,et al.  Tissue distribution and pharmacokinetics of stable polyacrylamide nanoparticles following intravenous injection in the rat. , 2011, Toxicology and applied pharmacology.

[2]  Yong-Eun Koo Lee,et al.  F3-targeted cisplatin-hydrogel nanoparticles as an effective therapeutic that targets both murine and human ovarian tumor endothelial cells in vivo. , 2010, Cancer research.

[3]  Pai-Chi Li,et al.  In vivo photoacoustic molecular imaging with simultaneous multiple selective targeting using antibody-conjugated gold nanorods , 2008 .

[4]  Minghua Xu,et al.  Time-domain reconstruction for thermoacoustic tomography in a spherical geometry , 2002, IEEE Transactions on Medical Imaging.

[5]  G. E. Moore,et al.  Fluorescein as an Agent in the Differentiation of Normal and Malignant Tissues. , 1947, Science.

[6]  Geng Ku,et al.  Noninvasive photoacoustic angiography of animal brains in vivo with near-infrared light and an optical contrast agent. , 2004, Optics letters.

[7]  Erkki Ruoslahti,et al.  Nanocrystal targeting in vivo , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[8]  Oren Sagher,et al.  The Brain Tumor Window Model: A Combined Cranial Window and Implanted Glioma Model for Evaluating Intraoperative Contrast Agents , 2010, Neurosurgery.

[9]  Lihong V. Wang,et al.  Universal back-projection algorithm for photoacoustic computed tomography. , 2005 .

[10]  D. A. Hansen,et al.  Indocyanine green (ICG) staining and demarcation of tumor margins in a rat glioma model. , 1993, Surgical neurology.

[11]  Raoul Kopelman,et al.  Brain cancer diagnosis and therapy with nanoplatforms. , 2006, Advanced drug delivery reviews.

[12]  Raoul Kopelman,et al.  Nanoparticle PEBBLE sensors in live cells and in vivo. , 2009, Annual review of analytical chemistry.

[13]  Erkki Ruoslahti,et al.  A fragment of the HMGN2 protein homes to the nuclei of tumor cells and tumor endothelial cells in vivo , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[14]  Nina M. Muñoz,et al.  Tumor paint: a chlorotoxin:Cy5.5 bioconjugate for intraoperative visualization of cancer foci. , 2007, Cancer research.

[15]  M. Berger,et al.  Intracarotid RMP-7 Enhanced Indocyanine Green Staining of Tumors in a Rat Glioma Model , 2002, Journal of Neuro-Oncology.

[16]  D. Orringer,et al.  Small Solutions for Big Problems: The Application of Nanoparticles to Brain Tumor Diagnosis and Therapy , 2009, Clinical pharmacology and therapeutics.

[17]  F. Zanella,et al.  Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. , 2006, The Lancet. Oncology.

[18]  Zhuang Liu,et al.  Carbon nanotubes as photoacoustic molecular imaging agents in living mice. , 2008, Nature nanotechnology.

[19]  D. Orringer,et al.  IN VITRO CHARACTERIZATION OF A TARGETED, DYE‐LOADED NANODEVICE FOR INTRAOPERATIVE TUMOR DELINEATION , 2009, Neurosurgery.

[20]  Lihong V. Wang,et al.  Noninvasive laser-induced photoacoustic tomography for structural and functional in vivo imaging of the brain , 2003, Nature Biotechnology.

[21]  E Ruoslahti,et al.  Vascular homing peptides with cell-penetrating properties. , 2005, Current pharmaceutical design.

[22]  Raoul Kopelman,et al.  Vascular Targeted Nanoparticles for Imaging and Treatment of Brain Tumors , 2006, Clinical Cancer Research.

[23]  Feng Gao,et al.  In vivo molecular photoacoustic tomography of melanomas targeted by bioconjugated gold nanocages. , 2010, ACS nano.

[24]  Yasuhiko Kaku,et al.  Fluorescence-guided resection of glioblastoma multiforme by using high-dose fluorescein sodium. Technical note. , 2003, Journal of neurosurgery.

[25]  Scott VandenBerg,et al.  Bromophenol Blue Staining of Tumors in a Rat Glioma Model , 2005, Neurosurgery.

[26]  Chulhong Kim,et al.  Sentinel lymph nodes and lymphatic vessels: noninvasive dual-modality in vivo mapping by using indocyanine green in rats--volumetric spectroscopic photoacoustic imaging and planar fluorescence imaging. , 2010, Radiology.

[27]  M. Berger,et al.  GLIOMA EXTENT OF RESECTION AND ITS IMPACT ON PATIENT OUTCOME , 2008, Neurosurgery.